ScanSource, Inc. filings document the reporting obligations of a Nasdaq-listed technology distributor with common stock traded under SCSC. Recent Form 8-K disclosures cover quarterly and fiscal-year operating results, earnings exhibits, Regulation FD materials, executive appointments, board leadership updates and changes in the company’s independent registered public accounting firm.
The company’s proxy materials provide governance and shareholder-meeting disclosures, while periodic reporting referenced in its earnings filings frames results against annual and quarterly reports. These records center on operating performance, financial presentation, corporate governance, auditor oversight and the capital-market status of ScanSource common stock.
ScanSource reported higher sales and earnings for the quarter and nine months ended March 31, 2026. Quarterly net sales rose to $766.8 million from $704.8 million, driven mainly by the Specialty Technology Solutions segment, while Intelisys & Advisory was roughly flat.
Quarterly net income was $16.9 million versus $17.4 million a year earlier, but diluted EPS increased to $0.78 from $0.74 on a lower share count after buybacks. For the first nine months, net sales reached $2.27 billion and net income $53.3 million. Operating cash flow was strong at $125.4 million, funding acquisitions and about $71.4 million of share repurchases, while total debt fell to $102.0 million with cash of $120.3 million.
ScanSource, Inc. reported higher third-quarter fiscal 2026 revenue and solid cash generation while raising its full-year free cash flow outlook. Net sales for the quarter ended March 31, 2026 rose 8.8% year-over-year to $766.8 million, driven mainly by 9.2% growth in the Specialty Technology Solutions segment. Gross profit increased 6.9% to $107.1 million, with a 14.0% margin.
GAAP net income was $16.9 million and diluted EPS was $0.78, up from $0.74 a year earlier. Non-GAAP diluted EPS increased to $0.94. Adjusted EBITDA was $35.6 million, or 4.65% of net sales. Year-to-date operating cash flow reached $125.4 million and free cash flow $118.6 million. The company reaffirmed fiscal 2026 net sales guidance of $3.0–$3.1 billion and adjusted EBITDA of $140–$150 million, and raised its non-GAAP free cash flow outlook from at least $80 million to at least $90 million. As of March 31, 2026, ScanSource held $120.3 million in cash and cash equivalents and $102.0 million of total debt, resulting in net cash and a trailing twelve-month adjusted EBITDA of $144.0 million.
ScanSource Inc reports a Schedule 13G filing showing Vanguard Portfolio Management beneficially owns 1,799,139 shares of Common Stock. The filing lists this as 8.37% of the class and shows Vanguard has sole dispositive power for 1,799,139 shares and sole voting power for 34,148 shares.
ScanSource Inc ownership update: The Vanguard Group filed an amendment stating it reports certain subsidiaries on a disaggregated basis after an internal realignment. The filing shows amount beneficially owned: 0 shares representing 0% of Common Stock. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
The amendment cites SEC Release No. 34-39538 (January 12, 1998) as the basis for separate reporting and states the subsidiaries pursue the same investment strategies previously followed.
SCANSOURCE, INC. executive Michael Reed Webb, who serves as SVP & Chief HR Officer, filed an initial insider ownership report. The Form 3 shows that he currently has no securities beneficially owned in the company, with total direct holdings reported as zero shares following this filing.
ScanSource, Inc. CEO Michael L. Baur reported open-market sales of 25,000 shares of common stock. The transactions occurred on March 13 and March 16, with weighted average prices around $35.76, $36.40, and $35.89 per share.
The filing notes these were executed through multiple trades within price ranges from approximately $35.33 to $36.67. After these sales, Baur directly owns 157,512 shares of ScanSource common stock, indicating he retains a substantial equity position in the company.
SCANSource (SCSC) Form 144 reports proposed and completed sales of Common Stock by Michael Baur. The filing lists sales on 09/17/2025 of 102,031 shares for $4,587,290.91 and on 09/18/2025 of 47,969 shares for $2,126,809.23. Additional sales are reported on 12/12/2025 (982 shares for $41,334.35), 12/15/2025 (9,559 shares for $390,240.61), and 12/16/2025 (9,459 shares for $391,830.90).
The filing also records equity vesting events in August–September 2025 for performance shares and restricted stock units totaling listed grants of 1,721; 3,208; 7,802; and 12,269 shares on the dates shown. The Form 144 discloses transaction dates and amounts; cash‑flow treatment and registration specifics are those standard to Section 144 notices.
ScanSource, Inc. reported leadership changes in its senior management team. Effective March 16, 2026, Alexandre Conde, currently Senior Executive Vice President and Chief People Officer, will shift roles to become Senior Executive Vice President, Strategy. On March 6, 2026, the company hired Michael Webb, who will join ScanSource on March 16, 2026 as Senior Executive Vice President, Chief Human Resources Officer. These moves realign executive responsibilities around strategy and human resources while keeping Conde in a key leadership role focused on strategic initiatives.
ScanSource director Mathis Charles Alexander bought additional company stock in two open-market transactions. On 02/11/2026, he purchased 5,000 shares of common stock at a weighted average price of $35.32 and 1,000 shares at $34.63. Following these trades, he directly owned 24,793 shares. The larger purchase was executed through multiple trades between $34.92 and $35.63.
ScanSource, Inc. reported slightly higher revenue but mixed profit trends for the quarter and six months ended December 31, 2025. Quarterly net sales were $766.5 million, up from $747.5 million a year earlier, while net income edged down to $16.5 million from $17.1 million, with diluted EPS at $0.75 versus $0.70.
For the first six months, net sales were $1.51 billion compared with $1.52 billion, but net income rose to $36.4 million from $34.0 million, and diluted EPS increased to $1.63 from $1.39, helped by better gross margins and lower restructuring costs. Operating cash flow strengthened to $54.1 million from $38.6 million, supporting continued share repurchases and the October 2025 acquisition of DataXoom, which added goodwill and intangible assets.
ScanSource entered a new five-year credit agreement in December 2025, providing a $400 million multicurrency revolving facility and a $100 million term loan, and reduced total debt to $102.7 million from $136.1 million. Management highlights ongoing macroeconomic uncertainty, including inflation, tariffs and foreign exchange volatility, and is assessing the impact of new U.S. tax legislation enacted in 2025.